Show 10 5 10 15 20 50 100 250 Sort by year (new to old) Actions Download search results Subscribe to news feed Your filters: cql: author="Ferenci, Peter" or (type any "bookEditor journalEditor issueEditor" and editor="Ferenci, ... Add to list Journal Article A1 open access Ribavirin dose management in HCV patients receiving ombitasvir/paritaprevir/ritonavir and dasabuvir with ribavirin Jordan J Feld, David E Bernstein, Ziad Younes, Hans Van Vlierberghe (UGent) , Lois Larsen, Fernando Tatsch and Peter Ferenci (2018) LIVER INTERNATIONAL. 38(9). p.1571-1575 Add to list Journal Article A1 open access Impact of safety-related dose reductions or discontinuations on sustained virologic response in HCV-infected patients : results from the GUARD-C cohort Graham R. Foster, Carmine Coppola, Moutaz Derbala, Peter Ferenci, Alessandra Orlandini, K. Rajender Reddy, Ludovico Tallarico, Mitchell L. Shiffman, Silke Ahlers, Georgios Bakalos, et al. (2016) PLOS ONE. 11(3). Add to list Journal Article A1 open access Telaprevir for retreatment of HCV infection Stefan Zeuzem, Pietro Andreone, Stanislas Pol, Eric Lawitz, Moises Diago, Stuart Roberts, Roberto Focaccia, Zobair Younossi, Graham R Foster, Andrzej Horban, et al. (2011) NEW ENGLAND JOURNAL OF MEDICINE. 364(25). p.2417-2428